-
421
Development of T-cell engagers selective for cells co-expressing two antigens
Published 2022-12-01Get full text
Article -
422
-
423
Multi-range ERK responses shape the proliferative trajectory of single cells following oncogene induction
Published 2023-03-01Get full text
Article -
424
Baseline risk factors associated with immune related adverse events and atezolizumab
Published 2023-02-01Get full text
Article -
425
The role of mitochondrial genes on nuclear gene expression in neovascular age related macular degeneration: analysis of nuclear VEGF gene expression after ranibizumab treatment in...
Published 2023-07-01“…The cybrids were treated with Ranibizumab (Lucentis, Genentech, San Francisco, CA), at 4 different concentrations for 24 h, and subsequently the levels of reactive oxygen species (ROS), gene expression for VEGF-A, hypoxia-inducible factor 1-alpha (HIF1-a) and manganese superoxide dismutase (SOD2) were measured. …”
Get full text
Article -
426
-
427
Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in par...
Published 2023-04-01“…Hoffmann-La Roche Ltd/Genentech) and local standard-of-care support, with/without the Roche DPM Module. …”
Get full text
Article -
428
Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening
Published 2023-10-01“…(Basel, Switzerland)/Genentech, Inc. (South San Francisco, CA, USA), on 6 November 2017. …”
Get full text
Article -
429
Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation
Published 2022-06-01Get full text
Article -
430
-
431
-
432
SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
Published 2018-02-01“…HIGHLIGHTSPreliminary results of this work were presented at the 2016 Academic Surgical Congress, Jacksonville (FL), February 2–4 2016 (Original title: Selective Smo-Inhibition Interferes With Cellular Energetic Metabolism In Colorectal Cancer)This study was funded by “Sapienza—University of Rome” (Funds for young researchers) and “AIRC” (Italian Association for Cancer Research)Hedgehog inhibitor was kindly provided by Genentech, Inc.®.Colon Cancer (CC) is the fourth most frequently diagnosed tumor and the second leading cause of death in the USA. …”
Get full text
Article -
433
-
434
-
435
-
436
-
437
-
438
-
439
-
440
Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling
Published 2023-06-01Get full text
Article